| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.4 |